Kepler Capital analyst Nicolas Pauillac maintained a Buy rating on MedinCell SA (MEDCL – Research Report) on February 26 and set a price ...

The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of ...

European STOXX Europe 600 Index experienced a modest rise, reflecting investor sentiment shaped by U.S. trade policy developments and geopolitical efforts to resolve the Russia-Ukraine conflict. In ...

As the European markets navigate cautious optimism amid geopolitical tensions and evolving trade policies, investors are keenly observing growth opportunities within the region. In this landscape, ...